You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.

Bringing Linaclotide to Patients Around the World

Ironwood has built the team and capabilities to deliver linaclotide to patients in the United States. But our goal is to get this medicine to appropriate patients around the world, in the most efficient way possible, and we’re committed to working with our network of partners both in the U.S. and in other countries to achieve that goal.

NORTH AMERICA

LINZESS®* available in U.S. through 50/50 collaboration

EUROPE

CONSTELLA® available
in certain European countries through partnership

CHINA

Under review by
regulatory authority
for potential approval

JAPAN

LINZESS® approved in Japan through partnership